Atherosclerosis and macrovascular involvement in systemic sclerosis: Myth or reality

Autoimmunity Reviews

Volumn 10, Issue 5, 2011, Pages 259-266

  Nussinovitch, Udi ^a   Shoenfeld, Yehuda ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Angiography; Atherosclerosis; Autoimmunity; Systemic sclerosis (SSc)

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIAL CELL ANTIBODY; GLYCERYL TRINITRATE; HEAT SHOCK PROTEIN 70; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY;

ANKLE BRACHIAL INDEX; ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ARTERY BLOOD FLOW; CORONARY FLOW RESERVE; ECHOGRAPHY; ERECTILE DYSFUNCTION; HEART MUSCLE PERFUSION; HUMAN; INTERMITTENT CLAUDICATION; REVASCULARIZATION; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; THROMBOSIS; VASODILATATION;

ATHEROSCLEROSIS; AUTOIMMUNE DISEASES; CAROTID ARTERIES; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; FEMALE; FIBROSIS; HUMANS; MALE; RHEUMATIC DISEASES; RISK FACTORS; SCLERODERMA, SYSTEMIC; TUNICA INTIMA; TUNICA MEDIA;

EID: 79952039780     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2010.09.014     Document Type: Review

References (81)

1. Zandman-Goddard G., Tweezer-Zaks N., Shoenfeld Y. New therapeutic strategies for systemic sclerosis-a critical analysis of the literature. Clin Dev Immunol 2005, 12:165-173.
2. Nacci F., Righi A., Conforti M.L., Miniati I., Fiori G., Martinovic D., et al. Intravenous immunoglobulins improve the function and ameliorate joint involvement in systemic sclerosis: a pilot study. Ann Rheum Dis 2007, 66:977-979.
3. Bartoli F., Blagojevic J., Bacci M., Fiori G., Tempestini A., Conforti M.L., et al. Flow-mediated vasodilation and carotid intima-media thickness in systemic sclerosis. Ann NY Acad Sci 2007, 1108:283-290.
4. Belch J.J., McSwiggan S., Lau C. Macrovascular disease in systemic sclerosis: the tip of an iceberg?. Rheumatology (Oxford) 2008, 47(Suppl 5):v16-v17.
5. Wan M.C., Moore T., Hollis S., Herrick A.L. Ankle brachial pressure index in systemic sclerosis: influence of disease subtype and anticentromere antibody. Rheumatology (Oxford) 2001, 40:1102-1105.
6. Arnson Y., Amital H., Guiducci S., Matucci-Cerinic M., Valentini G., Barzilai O., et al. The role of infections in the immunopathogensis of systemic sclerosis-evidence from serological studies. Ann NY Acad Sci 2009, 1173:627-632.
7. Akram M.R., Handler C.E., Williams M., Carulli M.T., Andron M., Black C.M., et al. Angiographically proven coronary artery disease in scleroderma. Rheumatology (Oxford) 2006, 45:1395-1398.
8. Weiss S., Stead E.J., Warren J., Bailey O. Scleroderma heart disease with a consideration of certain other visceral manifestations of scleroderma. Arch Intern Med 1943, 71:749.
9. Kahan A., Coghlan G., McLaughlin V. Cardiac complications of systemic sclerosis. Rheumatology (Oxford) 2009, 48(Suppl 3):iii45-iii48.
10. Bulkley B.H., Ridolfi R.L., Salyer W.R., Hutchins G.M. Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction. Circulation 1976, 53:483-490.
11. Tarek el G., Yasser A.E., Gheita T. Coronary angiographic findings in asymptomatic systemic sclerosis. Clin Rheumatol 2006, 25:487-490.
12. Montisci R., Vacca A., Garau P., Colonna P., Ruscazio M., Passiu G., et al. Detection of early impairment of coronary flow reserve in patients with systemic sclerosis. Ann Rheum Dis 2003, 62:890-893.
13. Aguglia G., Sgreccia A., Bernardo M.L., Carmenini E., Giusti De Marle M., Reali A., et al. Left ventricular diastolic function in systemic sclerosis. J Rheumatol 2001, 28:1563-1567.
14. Valentini G., Vitale D.F., Giunta A., Maione S., Gerundo G., Arnese M., et al. Diastolic abnormalities in systemic sclerosis: evidence for associated defective cardiac functional reserve. Ann Rheum Dis 1996, 55:455-460.
15. Nakajima K., Taki J., Kawano M., Higuchi T., Sato S., Nishijima C., et al. Diastolic dysfunction in patients with systemic sclerosis detected by gated myocardial perfusion SPECT: an early sign of cardiac involvement. J Nucl Med 2001, 42:183-188.
16. Krause I., Shoenfeld Y. Intravenous immunoglobulin treatment for fibrosis, atherosclerosis, and malignant conditions. Methods Mol Med 2005, 109:403-408.
17. Shoenfeld Y., Gerli R., Doria A., Matsuura E., Cerinic M.M., Ronda N., et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 2005, 112:3337-3347.
18. Zinger H., Sherer Y., Shoenfeld Y. Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings. Clin Rev Allergy Immunol 2009, 37:20-28.
19. Szucs G., Timar O., Szekanecz Z., Der H., Kerekes G., Szamosi S., et al. Endothelial dysfunction precedes atherosclerosis in systemic sclerosis-relevance for prevention of vascular complications. Rheumatology (Oxford) 2007, 46:759-762.
20. Hettema M.E., Zhang D., de Leeuw K., Stienstra Y., Smit A.J., Kallenberg C.G., et al. Early atherosclerosis in systemic sclerosis and its relation to disease or traditional risk factors. Arthritis Res Ther 2008, 10:R49.
21. Zakopoulos N.A., Kotsis V.T., Gialafos E.J., Papamichael C.M., Pitiriga V., Mitsibounas D.N., et al. Systemic sclerosis is not associated with clinical or ambulatory blood pressure. Clin Exp Rheumatol 2003, 21:199-204.
22. Lippi G., Caramaschi P., Montagnana M., Salvagno G.L., Volpe A., Guidi G. Lipoprotein[a] and the lipid profile in patients with systemic sclerosis. Clin Chim Acta 2006, 364:345-348.
23. Cerinic M.M., Valentini G., Sorano G.G., D'Angelo S., Cuomo G., Fenu L., et al. Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis. Semin Arthritis Rheum 2003, 32:285-295.
24. Borba E.F., Borges C.T., Bonfa E. Lipoprotein profile in limited systemic sclerosis. Rheumatol Int 2005, 25:379-383.
25. Khurma V., Meyer C., Park G.S., McMahon M., Lin J., Singh R.R., et al. A pilot study of subclinical coronary atherosclerosis in systemic sclerosis: coronary artery calcification in cases and controls. Arthritis Rheum 2008, 59:591-597.
26. Herrick A.L., Illingworth K.J., Hollis S., Gomez-Zumaquero J.M., Tinahones F.J. Antibodies against oxidized low-density lipoproteins in systemic sclerosis. Rheumatology (Oxford) 2001, 40:401-405.
27. Nussinovitch U., Shoenfeld Y. Autoimmunity and heart diseases: pathogenesis and diagnostic criteria. Arch Immunol Ther Exp (Warsz) 2009, 57:95-104.
28. Sherer Y., Cerinic M.M., Bartoli F., Blagojevic J., Conforti M.L., Gilburd B., et al. Early atherosclerosis and autoantibodies to heat-shock proteins and oxidized LDL in systemic sclerosis. Ann NY Acad Sci 2007, 1108:259-267.
29. Ogawa F., Shimizu K., Hara T., Muroi E., Hasegawa M., Takehara K., et al. Serum levels of heat shock protein 70, a biomarker of cellular stress, are elevated in patients with systemic sclerosis: association with fibrosis and vascular damage. Clin Exp Rheumatol 2008, 26:659-662.
30. Zhu J., Quyyumi A.A., Wu H., Csako G., Rott D., Zalles-Ganley A., et al. Increased serum levels of heat shock protein 70 are associated with low risk of coronary artery disease. Arterioscler Thromb Vasc Biol 2003, 23:1055-1059.
31. Lopez L.R., Simpson D.F., Hurley B.L., Matsuura E. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement. Ann NY Acad Sci 2005, 1051:313-322.
32. Matsuura E., Kobayashi K., Inoue K., Lopez L.R., Shoenfeld Y. Oxidized LDL/beta2-glycoprotein I complexes: new aspects in atherosclerosis. Lupus 2005, 14:736-741.
33. Kodera M., Hayakawa I., Komura K., Yanaba K., Hasegawa M., Takehara K., et al. Anti-lipoprotein lipase antibody in systemic sclerosis: association with elevated serum triglyceride concentrations. J Rheumatol 2005, 32:629-636.
34. Timar O., Soltesz P., Szamosi S., Der H., Szanto S., Szekanecz Z., et al. Increased arterial stiffness as the marker of vascular involvement in systemic sclerosis. J Rheumatol 2008, 35:1329-1333.
35. Fischer K., Brzosko M., Walecka A., Ostanek L., Sawicki M. Antiendothelial cell antibodies as a risk factor of atherosclerosis in systemic lupus erythematosus. Ann Acad Med Stetin 2006, 52(Suppl 2):95-99.
36. van Haelst P.L., Kobold A.C., van Doormaal J.J., Tervaert J.W. AECA and ANCA in patients with premature atherosclerosis. Int Rev Immunol 2002, 21:19-26.
37. George J., Meroni P.L., Gilburd B., Raschi E., Harats D., Shoenfeld Y. Anti-endothelial cell antibodies in patients with coronary atherosclerosis. Immunol Lett 2000, 73:23-27.
38. Niemiec P., Zak I., Wita K. The D allele of angiotensin I-converting enzyme gene insertion/deletion polymorphism is associated with the severity of atherosclerosis. Clin Chem Lab Med 2008, 46:446-452.
39. Youssef P., Englert H., Bertouch J. Large vessel occlusive disease associated with CREST syndrome and scleroderma. Ann Rheum Dis 1993, 52:464-466.
40. Youssef P., Brama T., Englert H., Bertouch J. Limited scleroderma is associated with increased prevalence of macrovascular disease. J Rheumatol 1995, 22:469-472.
41. Veale D.J., Collidge T.A., Belch J.J. Increased prevalence of symptomatic macrovascular disease in systemic sclerosis. Ann Rheum Dis 1995, 54:853-855.
42. Hettema M.E., Bootsma H., Kallenberg C.G. Macrovascular disease and atherosclerosis in SSc. Rheumatology (Oxford) 2008, 47:578-583.
43. Dick E.A., Aviv R., Francis I., Hamilton G., Baker D., Black C., et al. Catheter angiography and angioplasty in patients with scleroderma. Br J Radiol 2001, 74:1091-1096.
44. Taylor M.H., McFadden J.A., Bolster M.B., Silver R.M. Ulnar artery involvement in systemic sclerosis (scleroderma). J Rheumatol 2002, 29:102-106.
45. Walker U.A., Tyndall A., Ruszat R. Erectile dysfunction in systemic sclerosis. Ann Rheum Dis 2009, 68:1083-1085.
46. Nehra A., Hall S.J., Basile G., Bertero E.B., Moreland R., Toselli P., et al. Systemic sclerosis and impotence: a clinicopathological correlation. J Urol 1995, 153:1140-1146.
47. Aversa A., Proietti M., Bruzziches R., Salsano F., Spera G. The penile vasculature in systemic sclerosis: a duplex ultrasound study. J Sex Med 2006, 3:554-558.
48. Ostojic P., Damjanov N. The impact of depression, microvasculopathy, and fibrosis on development of erectile dysfunction in men with systemic sclerosis. Clin Rheumatol 2007, 26:1671-1674.
49. Nowlin N.S., Brick J.E., Weaver D.J., Wilson D.A., Judd H.L., Lu J.K., et al. Impotence in scleroderma. Ann Intern Med 1986, 104:794-798.
50. Lekakis J., Mavrikakis M., Papamichael C., Papazoglou S., Economou O., Scotiniotis I., et al. Short-term estrogen administration improves abnormal endothelial function in women with systemic sclerosis and Raynaud's phenomenon. Am Heart J 1998, 136:905-912.
51. Bartoli F., Angotti C., Fatini C., Conforti M.L., Guiducci S., Blagojevic J., et al. Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis. Rheumatology (Oxford) 2007, 46:772-775.
52. Kaloudi O., Basta G., Perfetto F., Bartoli F., Del Rosso A., Miniati I., et al. Circulating levels of Nepsilon-(carboxymethyl)lysine are increased in systemic sclerosis. Rheumatology (Oxford) 2007, 46:412-416.
53. Roustit M., Simmons G.H., Baguet J.P., Carpentier P., Cracowski J.L. Discrepancy between simultaneous digital skin microvascular and brachial artery macrovascular post-occlusive hyperemia in systemic sclerosis. J Rheumatol 2008, 35:1576-1583.
54. Cheng K.S., Tiwari A., Boutin A., Denton C.P., Black C.M., Morris R., et al. Carotid and femoral arterial wall mechanics in scleroderma. Rheumatology (Oxford) 2003, 42:1299-1305.
55. Nordin A., Björnådal L., Jensen-Urstad K., Svenungsson E. ACR/ARHP 09 Scientific Meeting Philadelphia 2009, Vol. 454.
56. Kawasaki M., Ito Y., Yokoyama H., Arai M., Takemura G., Hara A., et al. Assessment of arterial medial characteristics in human carotid arteries using integrated backscatter ultrasound and its histological implications. Atherosclerosis 2005, 180:145-154.
57. Ho M., Veale D., Eastmond C., Nuki G., Belch J. Macrovascular disease and systemic sclerosis. Ann Rheum Dis 2000, 59:39-43.
58. Stafford L., Englert H., Gover J., Bertouch J. Distribution of macrovascular disease in scleroderma. Ann Rheum Dis 1998, 57:476-479.
59. Andersen G.N., Mincheva-Nilsson L., Kazzam E., Nyberg G., Klintland N., Petersson A.S., et al. Assessment of vascular function in systemic sclerosis: indications of the development of nitrate tolerance as a result of enhanced endothelial nitric oxide production. Arthritis Rheum 2002, 46:1324-1332.
60. Sfikakis P.P., Papamichael C., Stamatelopoulos K.S., Tousoulis D., Fragiadaki K.G., Katsichti P., et al. Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosis. Arthritis Rheum 2007, 56:1985-1993.
61. Lekakis J., Papamichael C., Mavrikakis M., Voutsas A., Stamatelopoulos S. Effect of long-term estrogen therapy on brachial arterial endothelium-dependent vasodilation in women with Raynaud's phenomenon secondary to systemic sclerosis. Am J Cardiol 1998, 82:1555-1557. A8.
62. Cypiene A., Laucevicius A., Venalis A., Dadoniene J., Ryliskyte L., Petrulioniene Z., et al. The impact of systemic sclerosis on arterial wall stiffness parameters and endothelial function. Clin Rheumatol 2008, 27:1517-1522.
63. D'Andrea A., Caso P., Cuomo S., Scotto di Uccio F., Scarafile R., Salerno G., et al. Myocardial and vascular dysfunction in systemic sclerosis: the potential role of noninvasive assessment in asymptomatic patients. Int J Cardiol 2007, 121:298-301.
64. Al-Qaisi M., Nott D.M., King D.H., Kaddoura S. Ankle Brachial Pressure Index (ABPI): an update for practitioners. Vasc Health Risk Manag 2009, 5:833-841.
65. Bulkley B.H., Klacsmann P.G., Hutchins G.M. Angina pectoris, myocardial infarction and sudden cardiac death with normal coronary arteries: a clinicopathologic study of 9 patients with progressive systemic sclerosis. Am Heart J 1978, 95:563-569.
66. Mok M., Chiu S., Lo Y., Mak H., Wong W., Khong P., et al. Coronary atherosclerosis using computed tomography coronary angiography in patients with systemic sclerosis. Scand J Rheumatol 2009, 1-5.
67. Sulli A., Ghio M., Bezante G.P., Deferrari L., Craviotto C., Sebastiani V., et al. Blunted coronary flow reserve in systemic sclerosis. Rheumatology (Oxford) 2004, 43:505-509.
68. Sulli A., Ghio M., Bezante G.P., Deferrari L., Craviotto C., Sebastiani V., et al. Blunted coronary flow reserve in systemic sclerosis: a sign of cardiac involvement in asymptomatic patients. Ann Rheum Dis 2004, 63:210-211.
69. Vacca A., Siotto P., Cauli A., Montisci R., Garau P., Ibba V., et al. Absence of epicardial coronary stenosis in patients with systemic sclerosis with severe impairment of coronary flow reserve. Ann Rheum Dis 2006, 65:274-275.
70. Kahan A., Devaux J.Y., Amor B., Menkes C.J., Weber S., Nitenberg A., et al. Nifedipine and thallium-201 myocardial perfusion in progressive systemic sclerosis. N Engl J Med 1986, 314:1397-1402.
71. Belloli L., Carlo-Stella N., Ciocia G., Chiti A., Massarotti M., Marasini B. Myocardial involvement in systemic sclerosis. Rheumatology (Oxford) 2008, 47:1070-1072.
72. Kobayashi H., Yokoe I., Hirano M., Nakamura T., Nakajima Y., Fontaine K.R., et al. Cardiac magnetic resonance imaging with pharmacological stress perfusion and delayed enhancement in asymptomatic patients with systemic sclerosis. J Rheumatol 2009, 36:106-112.
73. Vignaux O., Allanore Y., Meune C., Pascal O., Duboc D., Weber S., et al. Evaluation of the effect of nifedipine upon myocardial perfusion and contractility using cardiac magnetic resonance imaging and tissue Doppler echocardiography in systemic sclerosis. Ann Rheum Dis 2005, 64:1268-1273.
74. Fatini C., Guiducci S., Abbate R., Matucci-Cerinic M. Vascular injury in systemic sclerosis: angiotensin-converting enzyme insertion/deletion polymorphism. Curr Rheumatol Rep 2004, 6:149-155.
75. Champion H.C. The heart in scleroderma. Rheum Dis Clin North Am 2008, 34:181-190. viii.
76. Colaci M., Sebastiani M., Giuggioli D., Manfredi A., Rossi R., Modena M.G., et al. Cardiovascular risk and prostanoids in systemic sclerosis. Clin Exp Rheumatol 2008, 26:333-336.
77. Agmon-Levin N., Bat-sheva P.K., Barzilai O., Ram M., Lindeberg S., Frostegard J., et al. Antitreponemal antibodies leading to autoantibody production and protection from atherosclerosis in Kitavans from Papua New Guinea. Ann NY Acad Sci 2009, 1173:675-682.
78. Freire de Carvalho J., Sherer Y., Shoenfeld Y. The fine-tuning of anti-oxidized low-density lipoprotein antibodies in cardiovascular disease and thrombosis. Thromb Haemost 2007, 98:1157-1159.
79. Horvath L., Czirjak L., Fekete B., Jakab L., Prohaszka Z., Cervenak L., et al. Levels of antibodies against C1q and 60kDa family of heat shock proteins in the sera of patients with various autoimmune diseases. Immunol Lett 2001, 75:103-109.
80. Kivity S., Agmon-Levin N., Blank M., Shoenfeld Y. Infections and autoimmunity-friends or foes?. Trends Immunol 2009, 30:409-414.
81. Portugal L.R., Fernandes L.R., Pietra Pedroso V.S., Santiago H.C., Gazzinelli R.T., Alvarez-Leite J.I. Influence of low-density lipoprotein (LDL) receptor on lipid composition, inflammation and parasitism during Toxoplasma gondii infection. Microbes Infect 2008, 10:276-284.